The European Fee is demanding EU states take motion to stop a surge in Covid circumstances forward of the autumn and winter months.
On Friday (2 September), it launched a 15-page technique paper that goals to battle the virus that’s nonetheless killing some 2,300 folks each day all through the EU and Iceland, Liechtenstein and Norway.
Be a part of EUobserver right this moment
Grow to be an knowledgeable on Europe
Get prompt entry to all articles — and 20 years of archives.
14-day free trial.
… or subscribe as a bunch
“The Covid-19 pandemic remains to be very a lot with us. Collectively, we should act in a coordinated approach to keep away from one other surge of circumstances,” stated Stella Kyriakides, EU well being commissioner, stated in a tweet.
The paper recommends, amongst different issues, that EU states enhance vaccine uptake and guarantee further boosters for folks in danger, together with these over the age of 60 or prone to any extreme illness.
The paper notes a tripling of circumstances over the summer season months, which has since tapered off, however stays excessive amongst folks over the age of 65, and that vaccine uptake has barely modified.
Round 14 % of adults stay unvaccinated and simply over 35 % have but to obtain their first booster, it says.
The fee’s warning follows an announcement, by the European Medicines Company (EMA), that it had authorized two tailored variations of the Comirnaty and Spikevax vaccines.
These vaccines are designed to sort out completely different strains of the SARS‑CoV‑2 virus, with the intention to increase the immune response.
“Each can be utilized to re-vaccinate folks from 12 years of age we now have had their first two pictures of major vaccination,” the EMA’s Marco Cavaleri instructed reporters on Friday.
The 2 adaptive vaccines are authorised for revaccination no matter the kind of jab folks have obtained beforehand, he stated.
He additionally famous that each vaccines set off robust immune responses towards Omicron BA 1 and the unique virus in folks beforehand vaccinated.
“Particularly, they have been simpler at triggering immune responses towards the BA.1 sub-variant than the unique vaccines,” he stated.
